Table 2.
VivaGel | VivaGel Placebo | HEC Gel | All Arms | |
---|---|---|---|---|
Participants enrolled | 22 | 21 | 18 | 61 |
Study retention for all visits | 22 (100%) | 21 (100%) | 18 (100%) | 61 (100%) |
Percentage of gel use* | ||||
Excluding time on product hold | ||||
0.0% | 0 | 0 | 0 | 0 |
0.1% – 49.9% | 0 | 0 | 0 | 0 |
50% – 79.9% | 1 (5%) | 0 | 1 (6%) | 2 (3%) |
≥ 80.0% | 21 (95%) | 21 (100%) | 17 (94%) | 59 (97%) |
Including time on product hold | ||||
0.0% | 0 | 0 | 0 | 0 |
0.1% – 49.9% | 1 (5%) | 0 | 0 | 1 (2%) |
50% – 79.9% | 4 (18%) | 1 (5%) | 1 (6%) | 6 (10%) |
≥ 80.0% | 17 (77%) | 20 (95%) | 17 (94%) | 54 (89%) |
Up to Week 2 visit